On August 25, 2025, HUTCHMED (China) Limited disclosed that Dr. Weiguo Su, an Executive Director, would step down from his position as Chief Executive Officer for health reasons. As a response, the Board of Directors has named Mr. Johnny Cheng, also an Executive Director, as the Acting Chief Executive Officer alongside his current role as Chief Financial Officer. HUTCHMED is listed on Nasdaq/AIM under the ticker symbol HCM, as well as on HKEX under the ticker symbol 13.